鼻咽癌患者血清中针对爱泼斯坦-巴尔病毒复制激活蛋白的IgG抗体发生率较高。
A high incidence of serum IgG antibodies to the Epstein-Barr virus replication activator protein in nasopharyngeal carcinoma.
作者信息
Mathew A, Cheng H M, Sam C K, Joab I, Prasad U, Cochet C
机构信息
Nasopharyngeal Carcinoma Research Laboratory, University Malaya, Kuala Lumpur.
出版信息
Cancer Immunol Immunother. 1994 Jan;38(1):68-70. doi: 10.1007/BF01517172.
Abstract
The BamHI Z EBV replication activator (ZEBRA) protein is involved in the switch from latency to productive cycle of Epstein-Barr virus. A recombinant ZEBRA protein was synthesized and assessed in enzyme-linked immunosorbent assay (ELISA) for serum IgG response in nasopharyngeal carcinoma (NPC) patients. In 100 NPC serum samples that were positive for IgA to the EBV viral capsid antigen (VCA), 75% had IgG anti-ZEBRA antibodies. In contrast, only 3/83 (3.6%) serum samples from healthy donors and 2/50 (4%) from other cancers were positive for IgG to ZEBRA. Interestingly, in a selected group of 100 NPC sera negative for IgA to VCA, 25% contained IgG anti-ZEBRA antibodies. This suggests that the ELISA for IgG anti-ZEBRA may also identify earlier cases of NPC not detected by the conventional immunofluorescence test for IgA to VCA.
摘要
BamHI Z Epstein-Barr病毒复制激活因子（ZEBRA）蛋白参与了爱泼斯坦-巴尔病毒从潜伏期到增殖期的转换。合成了一种重组ZEBRA蛋白，并在酶联免疫吸附测定（ELISA）中评估鼻咽癌（NPC）患者的血清IgG反应。在100份对EBV病毒衣壳抗原（VCA）IgA呈阳性的NPC血清样本中，75%有IgG抗ZEBRA抗体。相比之下，来自健康供体的83份血清样本中只有3份（3.6%）以及来自其他癌症患者的50份血清样本中有2份（4%）对ZEBRA的IgG呈阳性。有趣的是，在一组选定的100份对VCA IgA呈阴性的NPC血清中，25%含有IgG抗ZEBRA抗体。这表明针对IgG抗ZEBRA的ELISA可能也能识别出传统的针对VCA IgA免疫荧光检测未发现的早期NPC病例。
相似文献
1
A high incidence of serum IgG antibodies to the Epstein-Barr virus replication activator protein in nasopharyngeal carcinoma.鼻咽癌患者血清中针对爱泼斯坦-巴尔病毒复制激活蛋白的IgG抗体发生率较高。
Cancer Immunol Immunother. 1994 Jan;38(1):68-70. doi: 10.1007/BF01517172.
2
Analyses of the prognostic significance of the Epstein-Barr virus transactivator ZEBRA protein and diagnostic value of its two synthetic peptides in nasopharyngeal carcinoma.爱泼斯坦-巴尔病毒反式激活因子ZEBRA蛋白在鼻咽癌中的预后意义分析及其两种合成肽的诊断价值
J Clin Virol. 2008 Feb;41(2):96-103. doi: 10.1016/j.jcv.2007.09.010. Epub 2007 Nov 19.
3
Antibody responses to recombinant Epstein-Barr virus antigens in nasopharyngeal carcinoma patients: complementary test of ZEBRA protein and early antigens p54 and p138.鼻咽癌患者对重组爱泼斯坦-巴尔病毒抗原的抗体反应：ZEBRA蛋白与早期抗原p54和p138的补充检测
J Clin Microbiol. 2001 Sep;39(9):3164-70. doi: 10.1128/JCM.39.9.3164-3170.2001.
4
Antibodies to the Epstein-Barr virus transactivator protein (ZEBRA) as a valuable biomarker in young patients with nasopharyngeal carcinoma.抗爱泼斯坦-巴尔病毒反式激活蛋白（ZEBRA）抗体作为年轻鼻咽癌患者的一种有价值的生物标志物。
Int J Cancer. 2000 Apr 1;86(1):71-5. doi: 10.1002/(sici)1097-0215(20000401)86:1<71::aid-ijc11>3.0.co;2-1.
5
Single-assay combination of Epstein-Barr Virus (EBV) EBNA1- and viral capsid antigen-p18-derived synthetic peptides for measuring anti-EBV immunoglobulin G (IgG) and IgA antibody levels in sera from nasopharyngeal carcinoma patients: options for field screening.用于检测鼻咽癌患者血清中抗爱泼斯坦-巴尔病毒（EBV）免疫球蛋白G（IgG）和IgA抗体水平的EB病毒（EBV）EBNA1和病毒衣壳抗原-p18衍生合成肽的单检测组合：现场筛查选项
J Clin Microbiol. 2006 Apr;44(4):1459-67. doi: 10.1128/JCM.44.4.1459-1467.2006.
6
Detection of IgA against Epstein-Barr virus BZLF-1 replication activator (ZEBRA) in sera of nasopharyngeal carcinoma patients with a recombinant ZEBRA protein.用重组ZEBRA蛋白检测鼻咽癌患者血清中针对爱泼斯坦-巴尔病毒BZLF-1复制激活因子（ZEBRA）的IgA
Zhonghua Yi Xue Za Zhi (Taipei). 1999 Jun;62(6):350-5.
7
EBV specific antibody-based and DNA-based assays in serologic diagnosis of nasopharyngeal carcinoma.基于EBV特异性抗体和DNA检测在鼻咽癌血清学诊断中的应用
Int J Cancer. 2003 Jul 10;105(5):706-9. doi: 10.1002/ijc.11130.
8
Expression of EBV antibody EA-IgA, Rta-IgG and VCA-IgA and SA in serum and the implication of combined assay in nasopharyngeal carcinoma diagnosis.血清中EB病毒抗体EA-IgA、Rta-IgG、VCA-IgA及SA的表达及其联合检测在鼻咽癌诊断中的意义
Int J Clin Exp Pathol. 2015 Dec 1;8(12):16104-10. eCollection 2015.
9
[Six anti-Epstein-Barr virus antibodies in healthy adults in a high risk area of nasopharyngeal carcinoma].[鼻咽癌高风险地区健康成年人中的六种抗爱泼斯坦-巴尔病毒抗体]
Ai Zheng. 2009 Aug;28(8):822-6. doi: 10.5732/cjc.009.10095.
10
Molecular diversity of Epstein-Barr virus IgG and IgA antibody responses in nasopharyngeal carcinoma: a comparison of Indonesian, Chinese, and European subjects.鼻咽癌中爱泼斯坦-巴尔病毒IgG和IgA抗体反应的分子多样性：印度尼西亚、中国和欧洲受试者的比较
J Infect Dis. 2004 Jul 1;190(1):53-62. doi: 10.1086/421245. Epub 2004 May 26.
引用本文的文献
1
Serum Anti-Zta and Anti-LMP1 Antibodies in Oropharyngeal Cancer Related to Epstein-Barr Virus-Diagnostic Usefulness.与爱泼斯坦-巴尔病毒相关的口咽癌中的血清抗Zta和抗LMP1抗体——诊断效用
Cancers (Basel). 2024 Jan 13;16(2):341. doi: 10.3390/cancers16020341.
2
Oncogenic Properties of the EBV ZEBRA Protein.EBV ZEBRA蛋白的致癌特性
Cancers (Basel). 2020 Jun 5;12(6):1479. doi: 10.3390/cancers12061479.
3
Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency.EBNA1的癌风险变体可解除爱泼斯坦-巴尔病毒游离体潜伏期的调控。
Oncotarget. 2017 Jan 31;8(5):7248-7264. doi: 10.18632/oncotarget.14540.
4
Development of a time-resolved fluorescence immunoassay for Epstein-Barr virus Zta IgA antibodies in human serum.人血清中EB病毒Zta IgA抗体时间分辨荧光免疫分析方法的建立。
Viral Immunol. 2015 Apr;28(3):179-83. doi: 10.1089/vim.2014.0126. Epub 2015 Feb 4.
5
Serum antibody response to lytic and latent Epstein-Barr virus antigens in undifferentiated nasopharyngeal carcinoma patients from an area of nonendemicity.非流行地区未分化鼻咽癌患者对裂解性和潜伏性爱泼斯坦-巴尔病毒抗原的血清抗体反应
Clin Vaccine Immunol. 2007 Apr;14(4):435-41. doi: 10.1128/CVI.00466-06. Epub 2007 Feb 28.
6
Matrix metalloproteinase 9 is induced by the Epstein-Barr virus BZLF1 transactivator.
Clin Exp Metastasis. 1999 Jul;17(5):431-6. doi: 10.1023/a:1006699003525.
7
Oligo-monoclonal immunoglobulins frequently develop during concurrent cytomegalovirus (CMV) and Epstein-Barr virus (EBV) infections in patients after renal transplantation.肾移植患者在同时感染巨细胞病毒（CMV）和爱泼斯坦-巴尔病毒（EBV）期间，常出现寡克隆单克隆免疫球蛋白。
Clin Exp Immunol. 1999 Dec;118(3):465-72. doi: 10.1046/j.1365-2249.1999.01084.x.
8
Antibody responses to defined epitopes in the Epstein-Barr virus BZLF1-encoded transactivator protein among human immunodeficiency virus-infected patients.人类免疫缺陷病毒感染患者对爱泼斯坦-巴尔病毒BZLF1编码的反式激活蛋白中特定表位的抗体反应。
Clin Diagn Lab Immunol. 1996 May;3(3):363-4. doi: 10.1128/cdli.3.3.363-364.1996.
9
Linear epitopes of the replication-activator protein of Epstein-Barr virus recognised by specific serum IgG in nasopharyngeal carcinoma.鼻咽癌中特异性血清IgG识别的EB病毒复制激活蛋白的线性表位
Cancer Immunol Immunother. 1995 Apr;40(4):251-6. doi: 10.1007/BF01519899.
本文引用的文献
1
Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, other head and neck neoplasms, and control groups.鼻咽癌、其他头颈部肿瘤及对照组中针对EB病毒的抗体。
J Natl Cancer Inst. 1970 Jan;44(1):225-31.
2
Epstein-Barr virus-associated antibody patterns in carcinoma of the post-nasal space.鼻后间隙癌中与爱泼斯坦-巴尔病毒相关的抗体模式
Clin Exp Immunol. 1969 Nov;5(5):443-59.
3
Direct evidence for the presence of Epstein-Barr virus DNA and nuclear antigen in malignant epithelial cells from patients with poorly differentiated carcinoma of the nasopharynx.来自鼻咽癌低分化癌患者的恶性上皮细胞中存在爱泼斯坦-巴尔病毒DNA和核抗原的直接证据。
Proc Natl Acad Sci U S A. 1974 Dec;71(12):4737-41. doi: 10.1073/pnas.71.12.4737.
4
Antibodies to herpes group viruses in patients with nasopharyngeal and other head and neck cancers.鼻咽癌及其他头颈癌患者中疱疹病毒组病毒的抗体
Cancer Res. 1974 May;34(5):1207-10.
5
EB virus-associated antibodies in Caucasian patients with carcinoma of the nasopharynx and in long-term survivors after treatment.
Int J Cancer. 1974 Mar 15;13(3):319-25. doi: 10.1002/ijc.2910130307.
6
EB-virus associated serology in malignant disease: antibody levels to viral capsid antigens (VCA), membrane antigens (MA) and early antigens(EA) in patients with various neoplastic conditions.恶性疾病中与EB病毒相关的血清学：各种肿瘤性疾病患者针对病毒衣壳抗原（VCA）、膜抗原（MA）和早期抗原（EA）的抗体水平。
Int J Cancer. 1972 Mar 15;9(2):353-64. doi: 10.1002/ijc.2910090214.
7
Demonstration of two distinct components in the early antigen complex of Epstein-Barr virus-infected cells.爱泼斯坦-巴尔病毒感染细胞早期抗原复合物中两个不同成分的证明。
Int J Cancer. 1971 Sep 15;8(2):272-82. doi: 10.1002/ijc.2910080212.
8
Transfection of a rearranged viral DNA fragment, WZhet, stably converts latent Epstein-Barr viral infection to productive infection in lymphoid cells.重排的病毒DNA片段WZhet的转染可使潜伏的爱泼斯坦-巴尔病毒感染在淋巴细胞中稳定地转变为增殖性感染。
Proc Natl Acad Sci U S A. 1987 Mar;84(5):1332-6. doi: 10.1073/pnas.84.5.1332.
9
Improved sensitivity of detection by avidin-biotin complex (ABC) immunocytochemistry in Epstein-Barr virus serology.抗生物素蛋白-生物素复合物（ABC）免疫细胞化学法在爱泼斯坦-巴尔病毒血清学检测中提高了检测灵敏度。
J Med Virol. 1989 Dec;29(4):311-4. doi: 10.1002/jmv.1890290417.
10
Serological markers in the diagnosis of histopathological types of nasopharyngeal carcinoma.
Eur J Surg Oncol. 1989 Aug;15(4):357-60.
Zotero 插件